These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4167716)

  • 41. [Pharmacologic profile of a new non-competitive antiadrenergic agent with an anti-angina potential--a derivative of amiodarone].
    Charlier R; Delaunois G; Bauthier J
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):234-52. PubMed ID: 4724571
    [No Abstract]   [Full Text] [Related]  

  • 42. [Studies on substances in the benzofuran group. 43. Angiotrophic, anti-inflammatory and fibrinolytic properties of benzarone].
    Chaillet F; Barchewitz G; Charlier R; Guilbert A; Colot M; Deltour G
    Arzneimittelforschung; 1970 Mar; 20(3):358-63. PubMed ID: 4392593
    [No Abstract]   [Full Text] [Related]  

  • 43. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
    Kawashima S; Liang CS
    Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 45. Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine.
    George T; Kaul CL; Grewal RS; Tahilramani R
    J Med Chem; 1971 Oct; 14(10):913-5. PubMed ID: 4398920
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
    Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
    Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart.
    Lubbe WF; McFadyen ML; Muller CA; Worthington M; Opie LH
    Am J Cardiol; 1979 Mar; 43(3):533-40. PubMed ID: 217261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs.
    Vatner SF; McRitchie RJ; Maroko PR; Patrick TA; Braunwald E
    J Clin Invest; 1974 Sep; 54(3):563-75. PubMed ID: 4152859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiovascular profile of BR 750 (2,6-dichlorobenzylideneaminoguanidine acetate).
    Saini RK; Caputi AP; Marmo E
    Farmaco Prat; 1973 Jul; 28(7):359-87. PubMed ID: 4724740
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of 1-(beta-naphthyl)nonyl-1-amine on respiration and the cardiovascular system].
    Pham-Huu-Chanh ; Buu-Hoï NP; Richert MT
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):276-83. PubMed ID: 5481483
    [No Abstract]   [Full Text] [Related]  

  • 51. Some cardiovascular effects of a series of aryloxyalkylamines. II.
    Augstein J; Austin WC; Bartram CA; Boscott RJ
    J Med Chem; 1966 Nov; 9(6):812-8. PubMed ID: 5972035
    [No Abstract]   [Full Text] [Related]  

  • 52. [Characteristic of the effect of catron on blood influx in the ischemic myocardium].
    Sapozhkov AV
    Farmakol Toksikol; 1970; 33(5):563-7. PubMed ID: 4395398
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
    Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
    [No Abstract]   [Full Text] [Related]  

  • 54. LV oxygen consumption and pressure-volume area: role of norepinephrine and verapamil.
    Chung N; Wu X; Ritman EL
    Am J Physiol; 1991 Jul; 261(1 Pt 2):H77-82. PubMed ID: 1858933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.
    Singh BN; Vaughan Williams EM
    Br J Pharmacol; 1970 Aug; 39(4):657-67. PubMed ID: 5485142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Norepinephrine depleting and antihypertensive effect of 4-methoxy-3,5-dihydroxyphenylalanine.
    Thoenen H; Gerold M; Haefely W; Huerlimann A
    Experientia; 1968 Feb; 24(2):158-9. PubMed ID: 4384506
    [No Abstract]   [Full Text] [Related]  

  • 57. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock.
    Cronin RF
    Am Heart J; 1967 Sep; 74(3):387-95. PubMed ID: 6041067
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular and myocardial metabolic effects of infusions of phenylephrine.
    Privitera PJ; Rosenblum I
    J Pharmacol Exp Ther; 1967 May; 156(2):325-30. PubMed ID: 6026262
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of noradrenaline on blood flow and oxygen consumption in normal and ischemic areas of myocardium.
    Marhsall RJ; Parratt JR
    Am Heart J; 1973 Nov; 86(5):653-62. PubMed ID: 4743334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.